Assay of Clinical Findings of Patients With Pancreatic Insulinoma-Tumor in Shariati Hospital in 1389-1392 Year



Nozari N¹ ; Pourshams A¹ Show Affiliations
Source: Govaresh Published:2015

Abstract

Background: Insulinoma was a rare pancreatic neuroendocrine tumor. Insulinoma was more likely to present as one small size tumor in head of pancreas in middle age. Surgery was a curative treatment.The aim of this study was to present clinical characteristics of insulinoma tumors in pancreas and their outcomes after tumor resection from a referral endosonography center in Iran.; Materials and Methods: This was cross sectional study from Nov 2010 to Nov 2013, all patients with clinical and biochemichal diagnosis of insulinoma entered to the study. Various characteristics likes, symptoms, laboratory and imaging findings, pathologic reports and their outcomes after surgery were recorded in a standard check list. Patients were followed for up to three years. All statistical analyses were performed SPSS software.; Results: A total of 42 patients (62% women; mean of age 40 years) were identified.All of patients reported Whipple's triad. Mean time from initiating of symptoms until diagnosis time was 14 months. The common blood type was O (n=22,52.3%).The mean tumor size was 2.7cm. 33.4% of endosonography reports show a solid tumor in the head of pancreas. Finding shows (n=36, 85%) of patients were treated surgically. Insulinoma tumor was confirmed in the pancreatic sample. Insulinoma recurrence have not report during the mean follow-up of 343 days in patients after tumor resection.; Conclusion: In this study, insulinoma tumors of pancreas (non-familial) were single with tumor size of less than 3 cm. Most of them located in the head of pancreas. Outcomes following complete resection of tumor were satisfactory and have not report tumor recurrenceduring up to 3 years follow up. These results were the same as reports from other countries.